Pituitary & hypothalamus

Long-term pituitary function and functional and patient-reported outcomes in severe acquired brain injury

Eur J EndocrinolPublished Prospective study

Authors' conclusion

Patients with severe acquired brain injury may develop long-term hypothalamus-pituitary insufficiency, with an equal occurrence in patients with TBI and NTBI. In both types of patients, mainly isolated deficiencies, most commonly affecting the gonadal axis, were seen. Insufficiencies were unrelated to functional outcomes and patient-reported outcomes, probably reflecting the complexity and heterogeneous manifestations in both patient groups.

Study context

Population
Patients admitted for inpatient neurorehabilitation after severe acquired brain injury; pituitary function assessed at a mean of 2.4 years after injury
Participants
42 vs 18
Exposure
Severe traumatic brain injury (TBI) vs severe nontraumatic brain injury (NTBI)
  • TBIn = 42
  • NTBIn = 18reference
Outcome
Prevalence of hypopituitarism
Follow-up
Mean of 2.4 years after the injury

Main finding

As reported in the abstract

Hypopituitarism

P = 0.23

Observational data: associations, not effects.

Further findings

Number of axes affected among patients with hypopituitarism

1 axis (13 hypogonadotropic hypogonadism, 1 GH deficiency)
14/17 (82%)
2 axes (1 hypogonadotropic hypogonadism and GH deficiency; 2 hypogonadotropic hypogonadism and AVP deficiency)
3/17 (18%)
Central hypoadrenalism or central hypothyroidism
0

Functional and patient-reported outcomes

In both TBI and NTBI, pituitary status was unrelated to functioning and ability scores at 1 year and to patient-reported outcome scores at a mean of 2.4 years

Original publication

Long-term pituitary function and functional and patient-reported outcomes in severe acquired brain injury. Eur J Endocrinol. Published 29 April 2024. doi:10.1093/ejendo/lvae047

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.